The effect of rTMS combined with repeated magnetic stimulation of Taichong (LR3) on depression: a randomized controlled trial

Shaanxi Provincial Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Sign the informed consent voluntarily;
•2. Meet the western medicine diagnosis standard of depression;
•3. It conforms to the diagnostic standard of depression in traditional Chinese medicine;
•4. Hamilton Depression Scale 7 < HAMD-17 <= 24;
•5. Aged 18-65 years old.

•1. Those diagnosed as other mental diseases, such as panic disorder, obsessive-compulsive disorder, schizophrenia, hypochondriasis, etc;
•2. The patients who had used western medicine of anti anxiety, anti depression, anti psychosis and the same kind of traditional Chinese medicine in the first 4 weeks before entering the group;
•3. Taking antidepressants or having antidepressant pharmacological effect without washout;
•4. Pregnant or preparing pregnant or lactating women;
•5. Hyperthyroidism, coronary heart disease, hypertension, irritable bowel syndrome and other endocrine, cardiovascular and digestive system diseases with depression;
•6. Patients with organic mental disorders, psychoactive substances, non addictive substances and postpartum depression;
•7. Patients who have a history of suicide or a tendency to commit suicide, with a suicide score >= 1 in HAMD-17;
•8. Patients who participated in or are participating in other clinical trials within 1 month before enrollment;
•9. Magnetic metal objects implanted near the head or in the brain, such as intracranial stent, cochlear implant, etc;
•10. No monitoring or failure to complete the clinical study.

发起方

Shaanxi Provincial Chinese Medicine Hospital